Rolvedon Injection, Solution
Product Images NDC 82497-132

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Rolvedon (NDC 82497-132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Assertio Specialty Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duration Of Severe Neutropenia (dsn) Graphs (Image 01)

This information shows the percentage of patients experiencing severe neutropenia in two separate studies. Study 1 had 406 participants, while Study 2 had 237 participants. The data includes the duration of severe neutropenia in Cycle 1, with percentages ranging from 0% to 100%. It also mentions the resolution of severe neutropenia with the use of DPegfilgrastim treatment.*

FDA Label Image

Rolvedon Prefilled Syringe (Image 05)

FDA Label Image

Figure A (Image 06)

This appears to be a description for a medical device, possibly a syringe or a similar medical tool. It seems to mention components such as a needle cap, finger grip, plunger rod, plunger head, and viewing window guard clips. The text suggests instructions for use before and after utilizing the device.*

FDA Label Image

Figure B (Image 07)

FDA Label Image

Figure C (Image 08)

FDA Label Image

Figure H (Image 09)

This is a list of body parts to evaluate for fitness or health programs. The text mentions the outer part of the upper arm, abdomen, upper outer buttock, and upper outer thigh. These areas are commonly targeted in exercises to improve strength, flexibility, or muscle tone.*

FDA Label Image

Figure J (Image 10)

FDA Label Image

Figure K (Image 11)

FDA Label Image

Figure L (Image 12)

FDA Label Image

Figure M (Image 13)

FDA Label Image

Figure N (Image 14)

FDA Label Image

Figure O (Image 15)

This is a description of a sharps container. It is a specialized container used for the safe disposal of needles, syringes, and other sharp medical instruments. Sharps containers are designed to prevent injuries and infections by providing a secure and puncture-resistant storage solution for used sharps. Medical facilities, laboratories, and other environments where medical procedures are performed typically use sharps containers to ensure proper and safe disposal of sharps waste.*

FDA Label Image

Figure D (Image 16)

FDA Label Image

Figure E (Image 17)

FDA Label Image

Figure F (Image 18)

FDA Label Image

Figure G (Image 19)

FDA Label Image

Figure I (Image 20)

FDA Label Image

Blister Tray Label (Rolvedon Blister Tray Label)

This text provides information about a medication with the NDC code 82497-132-01, intended for prescription use. Each 0.6 mL pre-filled syringe contains 13.2 mg of eflapegrastim-xnst in a sterile, clear, colorless, preservative-free solution. The ingredients include citric acid, mannitol, polysorbate 80, and sodium chloride in Water for Injection. It is advised to store the medication refrigerated at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light. This product is a sterile solution, with no preservatives, manufactured by Assertio Specialty Pharmaceuticals in the USA. Further details on dosage should be obtained from the prescribing information.*

FDA Label Image

Carton Labeling (Rolvedon Carton Label)

FDA Label Image

Syringe Label (Rolvedon Syringe Label)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.